SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 374.33+0.7%Nov 18 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TobagoJack who wrote (16900)4/12/2007 6:24:10 PM
From: 8bits  Read Replies (1) of 217860
 
ipr aggression ... its ok ... follow the leader ... for it is all an emergency ... to provide work, to maintain social stability, to feed the people, etc etc, just ask around and query the spin doctors at Washington Post, and then People's Daily. What is the difference, except a matter of degree?

Pretty sure most Western nations (definitely Canada and Australia )with national health plans "negotiate" with US pharmaceutical companies to get lower prices on all drugs not just ones deemed to be part of national security or public health issues. If Germany demands this of US pharmaceuticals I see this as quid pro quo. A few anomalies in the system (such as treatment of agricultural subsidies by most Western nations..) do not mean we dispense entirely with free trade... the same applies to IPR.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext